Sponsor Pipeline

Context Therapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
8
Disease Areas
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06756035 CT-95 in Advanced Cancers Associated With Mesothelin Expression Mesothelin-Expressing Tumors Recruiting
NCT06515613 A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced… Platinum-resistant Ovarian Cancer Recruiting
NCT07545122 A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific… Triple Negative Breast Cancer (TNBC) Not Yet Recruiting
Disease Areas
Ovarian Cancer (2) Colorectal Cancer (2) Endometrial Cancer (1) Lung Cancer (1) Mesothelioma (1) Cholangiocarcinoma (1) Breast Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when Context Therapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free